A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.

NCT04765553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Rare Diseases

Interventions

DRUG: NI-0501
DRUG: Saline

Sponsor

Swedish Orphan Biovitrum